ABT
53
-3
ALL
37
-3
KLAC
57
3
RIG
54
7
CFG
48
-2
LEN
46
-3
PVH
62
2
EXPD
39
-11
F
40
-3
KMB
30
-3
HCP
52
9
AON
34
2
SYF
86
3
BXP
49
-3
CSCO
61
-3
URBN
70
-2
NI
67
2
DRI
48
-2
CMS
54
-3
SHW
53
-2
ABT
53
-3
ALL
37
-3
KLAC
57
3
RIG
54
7
CFG
48
-2
LEN
46
-3
PVH
62
2
EXPD
39
-11
F
40
-3
KMB
30
-3
HCP
52
9
AON
34
2
SYF
86
3
BXP
49
-3
CSCO
61
-3
URBN
70
-2
NI
67
2
DRI
48
-2
CMS
54
-3
SHW
53
-2
Financhill
Back

AllianzIM U.S. Large Cp Buffer10 Nov ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
44

NVBT
AllianzIM U.S. Large Cp Buffer10 Nov ETF

Last Price:
33.28
Seasonality Move:
3.04%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Sell
44
AllianzIM U.S. Large Cp Buffer10 Nov ETF (NVBT) is a Sell

Is AllianzIM U.S. Large Cp Buffer10 Nov ETF a Buy, Sell or Hold?

  • The current AllianzIM U.S. Large Cp Buffer10 Nov ETF [NVBT] share price is $33.19. The Score for NVBT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • NVBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVBT Stock Price Chart

What is AllianzIM U.S. Large Cp Buffer10 Nov ETF's stock price today?

  • The AllianzIM U.S. Large Cp Buffer10 Nov ETF share price today is $33.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVBT is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVBT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 69.38 Buy
Chaikin Money Flow: -453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.73 - 33.13) Buy
Bollinger Bands (100): (31.28 - 32.56) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

NVBT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.18 Buy
20-day SMA: 32.95 Buy
50-day SMA: 32.4 Buy
200-day SMA: 31.29 Buy
8-day EMA: 33.13 Buy
20-day EMA: 32.95 Buy
50-day EMA: 32.52 Buy
200-day EMA: 31.26 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

AllianzIM U.S. Large Cp Buffer10 Nov ETF Earnings Growth & NVBT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

AllianzIM U.S. Large Cp Buffer10 Nov ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):